Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 506 of 1,261

  1. US 10258686

    Materials and methods for respiratory disease control in canines

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEAS CONTROL AND PREVENTION · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  2. US 10258612

    Mitochondrial lipid permeable iron chelators for treating and preventing ischemia/reperfusion (I/R) injury in the heart following an ischemic event

    Northwestern University · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  3. US 10261095

    Predictive biomarkers of clinical response to anti-LPS immunoglobulin treatment

    Julius-Maximilians-Universitat Wurzburg · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  4. US 10258573

    Micronized insulin and micronized insulin analogues prepared under acidic conditions, and methods of manufacturing the same under acidic conditions

    Amphastar Pharmaceuticals, Inc. · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  5. US 10259870

    Anti-ANGPTL8 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  6. US 10258645

    Citrate containing beverage

    The Regents of the University of California · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  7. US 10258582

    Nicotinic receptor non-competitive antagonists

    Catalyst Biosciences, Inc. · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  8. US 10258627

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  9. US 10251778

    Therapeutics dispensing device and methods of making same

    The Regents of the University of California · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  10. US 10253039

    Inhibitors of bacterial DNA gyrase with efficacy against gram-negative bacteria

    The Regents of the University of California · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  11. US 10251894

    Anticonvulsant activity of steroids

    The Regents of the University of California · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  12. US 10251938

    Angiopoietin-based interventions for treating cerebral malaria

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  13. US 10251977

    Compositions and methods for tissue repair with extracellular matrices

    The Regents of the University of California · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  14. US 10251923

    Therapeutic uses of mastic gum fractions

    REGENERA PHARMA LTD. · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  15. US 10251896

    Compositions for improving cell viability and methods of use thereof

    Amylyx Pharmaceuticals, Inc. · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  16. US 10251881

    Particulate materials

    Nektar Therapeutics · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  17. US 10251851

    Bicyclic analgesic compounds

    Zeno Royalties & Milestones, LLC · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  18. US 10251874

    Crystalline forms of a JAK inhibitor compound

    Theravance Biopharma R&D IP, LLC · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  19. US 10251398

    Improving shelf life and color profile of resin compositions with silver nanoparticles

    The Board of Regents of the University of Texas System · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  20. US 10253297

    Stem cell aggregates and methods for making and using

    Regents of the University of Minnesota · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  21. US 10253424

    Porous particles and methods of making thereof

    The Board of Regents of the University of Texas System · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  22. US 10253333

    DNA-binding proteins and uses thereof

    Sangamo Therapeutics, Inc. · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  23. US 10253294

    Galactose oxidase treatment of dendritic cells to improve their immunogenicity

    Julius-Maximilians-Universitat Wurzburg · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  24. US 10253054

    Prodrugs of pyridone amides useful as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.